Chandra Kant Katiyar
Chandra Kant Katiyar publishes mostly in Complementary and alternative medicine, Pharmacology and Molecular Biology, on topics such as Phytochemicals and Medicinal Plants, Pharmacological Effects of Natural Compounds and Natural Antidiabetic Agents Studies.
- World rank
- #1,754,977 of 7,710,434 ranked researchers
- Rank in India
- #28,993 of 280,097
- Works
- 55
- Citations
- 1.1k
- Citations per work
- 20.9
What does Chandra Kant Katiyar research?
Chandra Kant Katiyar's work is mostly in Medicine (42%), Pharmacology, Toxicology and Pharmaceutics (15%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2342.3%
- Medicine2342.3%
- Life Sciences1731.7%
- Everything else1426.0%
- 1Complementary and alternative medicine28% of their works
- 2Pharmacology15% of their works
- 3Molecular Biology10% of their works
- 4Pharmacology8% of their works
- 5Plant Science7% of their works
- 6Endocrinology, Diabetes and Metabolism6% of their works
Research topics
- Phytochemicals and Medicinal Plants
- Pharmacological Effects of Natural Compounds
- Natural Antidiabetic Agents Studies
- Phytochemistry and Biological Activities
- Medicinal Plants and Neuroprotection
- Natural product bioactivities and synthesis
- Drug-Induced Hepatotoxicity and Protection
- Piperaceae Chemical and Biological Studies
Which keywords describe Chandra Kant Katiyar's research?
The keywords of their largest research topics: Antioxidant, Cancer, Neuroprotective, Ocimum sanctum, Withania somnifera, Antiviral, Pharmacology and Flavonoids.
- Saponins
- Pharmacological Properties
- Drug-Induced Liver Injury
- Phytochemistry
- Centella asiatica
- Insulin Resistance
- Licorice
- Triterpenoids
- Anti-inflammatory
- Antioxidants
- Flavonoids
- Antiviral
- Ocimum sanctum
- Cancer
- Antioxidant
- Neuroprotective
- Withania somnifera
- Pharmacology
- Medicinal Plants
- Oxidative Stress
- Biological Activities
- Glycyrrhizin
- Diabetes
- Bacopa monnieri
- Iridoids
- Anticancer
- Hepatotoxicity
- Piperine
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 28 words, with their numbers
- Antioxidant395 topics
- Cancer303 topics
- Neuroprotective273 topics
- Ocimum sanctum181 topic
- Withania somnifera181 topic
- Antiviral122 topics
- Pharmacology122 topics
- Flavonoids112 topics
- Medicinal Plants112 topics
- Antioxidants102 topics
- Oxidative Stress102 topics
- Anti-inflammatory92 topics
- Biological Activities92 topics
- Triterpenoids92 topics
- Glycyrrhizin81 topic
- Licorice81 topic
- Diabetes61 topic
- Insulin Resistance61 topic
- Bacopa monnieri51 topic
- Centella asiatica51 topic
- Iridoids51 topic
- Phytochemistry51 topic
- Anticancer41 topic
- Drug-Induced Liver Injury41 topic
- Hepatotoxicity41 topic
- Pharmacological Properties41 topic
- Piperine41 topic
- Saponins41 topic
Where does Chandra Kant Katiyar work?
Chandra Kant Katiyar's main affiliation in the publication record is Emami (India), India.
How many publications and citations does Chandra Kant Katiyar have?
OpenAlex counts 55 works and 1,149 citations for Chandra Kant Katiyar, an h-index of 15, ranking #1,754,977 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Chandra Kant Katiyar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.